advertisement
Grigera DE 1
Showing records 1 to 1 | Display all abstracts from Grigera DE22467 An eight-week, multicentric, randomized, interventional, open-label, phase-4, parallel comparison of the efficacy and tolerability of the fixed combination of timolol maleate 0.5%/brimonidine tartrate 0.2% versus fixed combination of timolol maleate 0.5%
Hatanaka M; Grigera DE; Barbosa WL; Jordao M; Susanna R Jr
Journal of Glaucoma 2008; 17: 674-679
